ArticleScientific reports2025
LASSO regression-based nomogram for distinguishing nontuberculous mycobacterial pulmonary disease from pulmonary tuberculosis: a clinical risk prediction model.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Development and internal validation of a LASSO-based clinical prediction model for nontuberculous mycobacterial pulmonary disease versus pulmonary tuberculosis.Frontiers in medicine · 2026Article
- Distinguishing nontuberculous mycobacterial lung disease from pulmonary tuberculosis using radiomics machine learning models from CT images.Frontiers in medicine · 2026Article
- Predictive Value of Nutritional Status in Sputum Culture Conversion Among Patients with Nontuberculous Mycobacterial Pulmonary Disease: A Retrospective Cohort Study.Infection and drug resistance · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
This study aims to identify predictive factors that can effectively distinguish between non-tuberculous mycobacterial pulmonary disease (NTM-PD) and pulmonary tuberculosis (PTB) by comparing their clinical characteristics and laboratory indicators, and to construct a risk prediction model based on these factors to improve the accuracy of clinical diagnosis, optimize treatment strategies, and reduce the risks of misdiagnosis and drug resistance. Data from 150 hospitalized patients treated at The Second People's Hospital of Fuyang City between January 2021 and December 2022 were collected, including 50 cases with NTM-PD and 100 cases with PTB. By gathering clinical data and laboratory inflammation markers of the patients, key predictive factors were identified using LASSO regression. These factors were further analyzed through univariate and multivariate logistic regression analysis to determine the influencing factors of NTM-PD, thereby constructing a nomogram prediction model. The accuracy of the model was evaluated through calibration curves, ROC curves, and Hosmer-Lemeshow goodness-of-fit tests, while its clinical utility was assessed using decision curve analysis and clinical impact curves.The two groups showed significant differences in age, BMI, bronchiectasis, and lung cavitation (P < 0.05). LASSO regression analysis identified age, BMI, bronchiectasis, and lung cavitation as four key variables. Multivariate logistic regression analysis revealed that old age, bronchiectasis, and lung cavitation were risk factors for NTM-PD, while low BMI acted as a protective factor. The nomogram model constructed based on these four variables demonstrated excellent predictive performance. The Hosmer-Lemeshow goodness-of-fit test indicated good model fit (P = 0.448), with an area under the ROC curve (AUC) of 0.861 (95% CI: 0.798-0.923). Decision curve and clinical impact curve analyses suggested that the model has the potential to optimize clinical decision-making within a threshold probability range of 0.05 to 0.75. By analyzing the critical differential characteristics between NTM-PD and PTB, we successfully developed a prediction model based on age, BMI, bronchiectasis, and lung cavitation, which effectively assesses the risk of NTM-PD occurrence, providing clinicians with a practical diagnostic aid.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.